Mylan Faces EpiPen Shortage as Slowing Sales Trip Up Its Results

Mylan NV’s EpiPen has been hard to find in some areas because of production problems, U.S. regulators said, as the drugmaker reported that declining sales of the lifesaving allergy-shot device weighed on its results.